AstraZeneca’s Imfinzi (durvalumab) has been granted priority review by the US Food and Drug Administration (FDA) to treat ...

Roche has shared new data from its Alzheimer’s disease (AD) development portfolio at this year’s Alzheimer’s Association ...

With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the ...

In a significant step towards tackling one of the UK’s most underdiagnosed conditions, North East and North Cumbria ...

AbbVie’s Elahere (mirvetuximab soravtansine) has been approved by the Medicines and Healthcare products Regulatory Agency ...

Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

AstraZeneca (AZ) has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into ...

LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...

We are thrilled to announce that Medscape Education has been honored with the SILVER Award in the Patient Education ...

Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, ...

Rain Free Days® is a free migraine support app created by Teva, 11 London, and the migraine community. It helps users track ...

The National Institute for Health and Care Excellence (NICE) has recommended ALK’s once-daily immunotherapy tablet to target ...